HGH 191AA (Somatropin）H10 10iu*10vials

HGH 191AA H10 10iu x 10 Vials

Product Overview

HGH 191AA H10 is a high-purity full-sequence recombinant human growth hormone research product in the H-series portfolio, representing an upgraded high-efficiency version optimized from the classic H8 specification. This product possesses a complete 191-amino acid full-length structure, supporting natural human growth hormone molecular sequence homology research, retaining biological activity and receptor-binding compatibility research characteristics. Utilizing advanced recombinant protein expression and aseptic vacuum freeze-drying technology, H10 10iu supports specific activity enhancement and downstream pathway activation intensity research compared to the 8iu specification. As a high-standard direct supplement of exogenous growth hormone, it supports endogenous pituitary gland dependence bypass research, achieving efficient stable linear high-amplitude growth hormone and insulin-like growth factor-1 axis upregulation research. This refined 10iu high-efficiency product is suitable for high-intensity body component anabolic metabolic remodeling research, deep cellular anti-aging intervention research, high-threshold metabolic regulation research, and high-standard complex peptide synergistic studies. It serves as a core reference substance for advanced growth hormone pharmacological mechanism verification and high-gradient preclinical efficacy studies.

Core Research Functions

GH and IGF-1 Downstream Signaling Cascade Activation: Supports GH and IGF-1 downstream signaling cascade full activation research, somatic cell proliferation comprehensive regulation, high-density lean tissue synthesis, systemic fat redistribution, and high-level energy metabolism studies.

Lean Muscle Growth and Damage Repair: Supports high-intensity lean muscle growth promotion research and damage repair studies.

Adipose Tissue Breakdown and Metabolic Remodeling: Supports deep adipose tissue breakdown research and metabolic remodeling studies, and basal metabolism significant enhancement research.

Cellular Senescence Inhibition: Supports cellular senescence effective inhibition research and high-standard somatic cell growth regulation studies.

Body Composition Optimization Mechanism Exploration: Supports advanced body composition optimization mechanism research and highly complex peptide combinations validation studies.

Compared to the moderate basal efficacy of H8 8iu, H10 10iu exhibits a comprehensive upgrade in core physiological phenotype, demonstrating superior performance in core research dimensions. Unlike endogenous pulsatile GHRH peptides, exogenous 191AA HGH supports hypothalamic-pituitary secretion function independence research, providing direct dose-proportionate growth hormone supplementation, supporting individual endogenous response differences elimination research and stable experimental results assurance research. The 10iu high-efficiency formulation supports powerful anabolic efficacy and scientific research safety threshold balance research, suitable for high-dose gradient modeling, high-intensity long-term metabolic interventions, advanced body composition optimization mechanism research, and highly complex peptide combinations validation, providing high-amplitude high-discrimination reproducible data for growth hormone pharmacology and high-threshold physiology in-depth research.

Core Product Advantages

191-Amino Acid All-Natural Homologous Structure: The complete full-length amino acid sequence of human growth hormone, supporting fragment truncation and structural mutations related studies. The molecular conformation supports natural human growth hormone consistency research, biological activity, and physiological simulation authenticity research, exceeding fragments and modified peptides in biological activity research.

Upgraded 10iu High-Efficiency Full-Spectrum Efficacy: The single-vial dose exceeds the traditional 8iu formulation, supporting growth hormone pathway activation amplitude and anabolic intensity significant enhancement research. It supports medium-dose product insufficient phenotypic differentiation related problem research, meeting high-intensity intervention study needs, providing research capabilities that exceed lower gradient specification efficacy ranges.

Direct Stable Exogenous Supplementation: Supports downstream metabolic and anabolic pathways independent activation research, without relying on endogenous endocrine function. It supports linear controllable dose-response relationship research, providing significant experimental phenotypes and supporting low systematic error research.

High Purity High Specific Activity Industrial-Grade Quality: Utilizing advanced gene recombination and multi-stage purification technologies, combined with a vacuum-locked lyophilization process. It preserves protein activity with stable specific activity and minimal heterologous protein interference, providing high-purity experimental variables and supporting reliable research conclusions.

Standardized High-Quality Aseptic Packaging: 10-vial integrated aseptic packaging. Each batch undergoes rigorous HPLC high-purity testing and is accompanied by a complete Certificate of Analysis (COA). With long-term activity stability and broad applicability, it is suitable for advanced laboratory research, key scientific research projects, preclinical drug development, and bulk wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 10iu per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).